Ticker brief
NUVB
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
15
authors 14d
11
crowd 14d
+0.2σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-21 · now +0.40 (−1 bearish … +1 bullish)
Who spoke11
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @zohmbastic | C | -1.38 | 2 | +0.20 |
| @SandmanMarkets | C | -2.91 | 2 | +0.38 |
| @Quantumup1 | C | · | 2 | +0.40 |
| @kkernttb | C | -2.19 | 2 | +0.55 |
| @Brad_E_Schulz | C | · | 1 | +0.50 |
| @MinervaCap | C | -0.39 | 1 | +0.50 |
| @Maximus_Holla | C | +0.80 | 1 | +0.50 |
| @Sir_Kory | C | -0.11 | 1 | +0.70 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @OzmosiHealth | C | · | 1 | +0.50 |
| @semodough | C | -3.01 | 1 | +0.40 |
Recent signals15of 15 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-21 | @semodough | +0.40 | Cantor initiates Nuvation Bio at Overweight, citing undervalued markets and best-in-class therapies. | · | tweet ↗ |
| 2026-08-21 | @Quantumup1 | +0.40 | Cantor initiated NUVB at Overweight with a $12 target and 73% implied upside | · | tweet ↗ |
| 2026-08-20 | @OzmosiHealth | +0.50 | Nuvation Bio received FDA Fast Track designation for safusidenib in IDH1-mutant glioma. | · | tweet ↗ |
| 2026-08-20 | @OpenOutcrier | +0.50 | The FDA granted Nuvation Bio fast-track status for its brain-cancer drug. | · | tweet ↗ |
| 2026-08-20 | @kkernttb | +0.50 | Positively highlights a strong NUVB price move. | · | tweet ↗ |
| 2026-08-19 | @Sir_Kory | +0.70 | Expresses confidence NUVB can reach $10 after an approximately 50% gain. | · | tweet ↗ |
| 2026-08-19 | @Maximus_Holla | +0.50 | Expects NUVB to move toward an $8 gap fill. | · | tweet ↗ |
| 2026-08-19 | @MinervaCap | +0.50 | Reports that previously held January $10 calls doubled during the sector move. | · | tweet ↗ |
| 2026-08-18 | @kkernttb | +0.60 | Highlights a bullish NUVB breakout on the attached chart. | · | tweet ↗ |
| 2026-08-18 | @Brad_E_Schulz | +0.50 | Quantifies daily sector breadth and performance, led by bio/pharma while semiconductors lag. | · | tweet ↗ |
| 2026-08-18 | @zohmbastic | +0.40 | JPMorgan initiates Nuvation Bio at Overweight with a $13 target. | · | tweet ↗ |
| 2026-08-18 | @Quantumup1 | +0.40 | JPMorgan initiated NUVB at Overweight with a $13 price target. | · | tweet ↗ |
| 2026-08-18 | @SandmanMarkets | +0.75 | Enter at market open, add at $5.88, and stop below $5.34. — Provides an explicit staged long setup with a defined stop. | · | tweet ↗ |
| 2026-08-18 | @SandmanMarkets | +0.00 | Lists four tickers on today's watch list and points to a setup thread. | · | tweet ↗ |
| 2026-08-17 | @zohmbastic | +0.00 | References NUVB's weekly chart without a stated direction. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.